Materials. Amino acids (L-lysine, L-histidine, L-alanine) were purchased from Iris Biotech GMBH (Germany). Trifluoromethanesulfonic acid (TFMSA), diisipropylcarbodiimide (DIC), 1-hydroxybenzotriazole (HOBt), thioanisole, ethanedithiol were purchased from Sigma-Aldrich (Germany) and used as received. Triethylamine (Et3N) and dichloromethane were purchased from Vecton Ltd. (Russia) and distilled before use. Dimethylformamide (DMF) was purchased from Vecton Ltd. (Russia), dried with 4 Å molecular sieves and distilled under vacuum. Trifluoroacetic acid (TFA) was purchased from Panreac (Spain) and distilled before application. All solvents were purified and distilled using standard procedures.
Instruments. Purification degree of the reaction product was assessed by RP-HPLC on Shimadzu LC-20 Prominence system (Japan) equipped with Luna C18 (2) column (5μm, 4.6 × 150 mm).
Synthesis and characterization.
Lys-2His dendrimer were synthesized by the solid peptide phase reaction (SPPS) that were performed manually in polypropylene syringes with a porous membrane on a polymeric support, pmethylbenzhydrylamine resin (capacity 0.85 mmol/g) using the BOC-strategy, DIC/HOBt as a condensing mixture, and trifluoroacetic acid for deblocking at the acylation stage. To protect functional groups of amino acids, the tertbutylhydroxycarbonyl (Boc) and p-benzyloxymethyl (Bom) groups were used. Alanine (Ala) residue was introduced at the C-terminus of the dendrimer. Nε, Nα-di-(tert-butylhydroxycarbonyl)lysine was introduced into the branching points and, subsequently, double the amount of amino acid derivatives were added. 4-N, Ndimethylaminopyridine (DMAP) was added to the reaction mixture as a catalyst for complete conversion on the last stage of the dendrimer growth. The effectiveness of coupling was checked by performing the Kaiser test. Then the resin was rinsed with DMF and dichloromethane (DCM). At the final stage of the synthesis the target dendrimer was cleaved from the polymeric carrier with complete deprotection of the TFMSA (1 mL)/TFA (10 mL) system in the presence of scavengers. After filtration the Lys-2His dendrimer was precipitated in ethyl ether (300 ml), centrifuged, and dried under vacuum.
Preliminary purification of the crude dendrimer was performed by gelfiltration on Sephadex G-50 column (2.5 × 50 cm) using 10% acetic acid as eluent.
The corresponding fraction was dialyzed against distilled water in a dialysis membrane bag (MWCO 1000) for one day. After two days of freeze drying, Lys2His dendrimer was collected. Purification degree of the product was analyzed by RP-HPLC in the water-acetonitrile-0.1% trifluoroacetic acid system using linear ascending acetonitrile gradient. The dendrimer fraction had a purity of 95%.
Thus, the general protocol includes the following stages: (1) deprotection, 70% TFA/CH 2 Cl 2 (10 ml), 15 min; (2) washing, CH 2 Cl 2 (10 ml × 2), DMF (10 ml × 2); (3) deprotonation, 10% Et 3 N/DMF (10 ml × 2), (4) washing, DMF, (10 ml × 2); (5) coupling, 1.5 mM Boc-amino acid, 15 mM DIC, 1.5 mM HOBt/DMF (10 ml); (6) washing, DMF (10 ml × 2), CH 2 Cl 2 (10 ml × 2); (7) the Kaiser test. In the case of incomplete coupling (positive ninhydrin reaction) the protocol is repeated from stage (3).
The principal scheme of the synthesis of Lys-2His dendrimer from the core to the first generation is presented in Fig. S1 . Figure S1 . The principal scheme of the synthesis of Lys-2His dendrimer from the core to the first generation.
We present the two-dimensional 1 H-13 C HSQC (Fig. S2) and HMBC ( Fig.   S3 and S4) NMR spectra of Lys-2His dendrimer to analyze its structure in detail. 
